Scripps Study Finds Opioid Users Could Benefit from Meth-Relapse Prevention Strategy

Monday, September 17, 2018

New research raises the possibility that a wider group of people battling substance abuse disorders may benefit from a Scripps Research-developed relapse-prevention compound than previously thought. The research, published recently in the journal Learning and Memory, shows that the compound appears to be effective even if multiple drugs of abuse are involved, such as methamphetamine in combination with either opioids or nicotine.